By regulating the production of inflammatory cytokines and the activity of immune cells, as well as activating tumor-associated signaling pathways like JAK/STAT and PI3K/AKT, resistin can indirectly promote cellular growth, angiogenesis, and immune response in the tumor microenvironment, facilitating lung cancer bone metastasis (145). This evidence concerns the gene AKT1 and neoplasm.